Biggest S&P 500 Movers on Tuesday

Advancers

• Tuesday's top performance in the S&P 500 belonged to shares of electricity generator NRG Energy (NRG), which surged 10.1% after 澳洲幸运5官方开奖结果体彩网:Jefferies upgraded the stock to "buy" from "hold" and lifted its price target. Analysts pointed to improved expectations for NRG's cross-selling opportunities. They also increased their estimates for earning🌞s before interest, taxes, depreciation, and am𒀰ortization (EBITDA) as they accounted for the company's growth plans.
• Shares of fellow power producer Constellation Energy (CEG) jumped 7.2% as the firm requested that U.S. regulators fast-track a review process to update rules related to connecting power plants directly with onsite data centers. The "co-location" of plants and data centers has been the subject of criticism, given potential risks to the reliability of surrounding power grids. Constellation, the largest operator of nuclear power plants in the U.S., said the unclear regulatory framework for co-location has impeded its plans to develop data centers adjacent to its power plant sites.
• J.M. Smucker (SJM) shares jumped 5.7% after the food maker r澳洲幸运5官方开奖结果体彩网:eported better-th🍸an-expected quarterly profits and boosted its full-year guidance. The company said robust demand for packaged and frozen foods, as well as higher coffee prices, helped drive the strong performance. However, Smucker expects a slump in convenience store traffic to weigh on sales for Hostess, the snack cake brand it acquired roughly a year ago.

• In government news Tuesday, the Biden administration recommended that 澳洲幸运5官方开奖结果体彩网:weight-loss drugs be covered under Medicare and Medicaid. The proposed changes would make popular anti-obesity treatments accessible to millions of additional patients in the U.S. starting in 2026. While costs for government health care programs would increase, there is a growing consensus that obesity is a chronic health condition that causes other ailments like diabetes and heart disease. Shares of Eli Lilly (LLY), maker of blockbuster GLP-1 agonists Zepbound and Mounjaro, gained 4.6% on Tuesday.

Decliners

• Shares of Super Micro Computer (SMCI) fell 10.4%, giving back a portion of the huge gains posted by the stock since the server maker submitted a compliance plan last week to maintain its listing on the Nasdaq as it addresses accounting issues. Although the submission helped allay delisting concerns, Supermicro remains the subject of an investigation by the Department of Justice and faces uncertainties related to its ability to capitalize on AI opportunities.
• General Motors (GM) shares skidded 9.0% following Trump's warning about levying a 25% tariff on goods from Canada and Mexico. GM has a significant manufacturing presence in both neighboring countries, but especially Mexico, where the automaker produces full-size pickup trucks. Shares of Chrysler parent Stellantis (STLA), which also has manufacturing facilities in Mexico, slipped 5.7%.
  
• Biopharmaceutical firm Amgen (AMGN) released data from a Phase II clinical trial of its weight-loss treatment MariTide. Although the study showed that patients who received injections experienced an average 20% drop in weight after a year, this result matched only the lower end of expectations, raising questions about how MariTide stacks up against competing treatments. Amgen shares dropped 4.8%.

-澳洲幸运5官方开奖结果体彩网:Michael Bromberg

Dell Tumbles in Extended Trading on Revenue Miss

Dell (DELL) p🔜osted third-quarter revenue that fell short of analysts’ expectations, sendin🙈g shares lower after the closing bell Tuesday. 

The server and personal com⭕puter maker delivered revenue of $24.4 billion, a 10% rise year-over-year but below the analyst consensus from Visible Alpha. Its net income of $1.13 billion, or $1.58 per share, was up from $1 billion, or $1.36 per share a year earlier, beating estimates.

Server and networking revenue rose 58% to $7.36 billion, driven in part by demand for 澳洲幸运5官方开奖结果体彩网:artificial intelligence (AI) servers. Server and networking revenue is part of Dell’s infrastructure solutions group, whichꦗ saw revenue rise 34% to $11.37 billion. 

The results come after Dell, which makes servers that utilize Nvidia (NVDA) AI chips, was 澳洲幸运5官方开奖结果体彩网:mentioned du🔯ring the chipmaker’s earnings call last week. 

Shares of Dell fell 8% in after-hours tradinꦬg following the release. They were up 85% from the start of the year through Tuesday’s close.

-澳洲幸运5官方开奖结果体彩网:Andrew Kessel

Eli Lilly, Novo Norodisk Rise on Biden Plan for Expanded Coverage of Weight Loss Drugs

Eli Lilly (LLY) and Novo Nordisk (NVO) shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' popular weight-loss drugs in government-backed healthcare plans including 澳洲幸运5官方开奖结果体彩网:Medicare and Medicaid.

Current rules limit weight-loss drugs from being covered by the programs, and the proposed changes would classify drugs such as Ozempic and Mounjaro as medications to treat obesity, with the reasoning that it can cause ailments like diabetes and heart disease, 澳洲幸运5官方开奖结果体彩网:which are covered under the rules.

Changing the classification would make the popular drugs available to millions of new patients across the U.S. starting in 2026, and raise costs for government healthcare programs. Over a 10-year period, the 澳洲幸运5官方开奖结果体彩网:Centers for Medicaid♋ and Medicare Services (CMS) estimates that the change would cost $24♛.8 billion for Medicare ❀and $14.8 billion for Medicaid.

The White House said the rule could reduce costs of the drugs, which can run over $1,000 for a month's supply, by up to 95%. Officials said they also expect prices of the drugs to decline over time as 澳洲幸运5官方开奖结果体彩网:more drugs enter the space and 澳洲幸运5官方开奖结果体彩网:competition increases, the Times reported.

Eli Lilly shares were up 4.5% in late trading Tuesday, while Novo Nordisk's U.S.-listed shares rose 1.5%.

-澳洲幸运5官方开奖结果体彩网:Aaron McDade

'Bitcoin $100K' Was So Near, Yet So Far—What's Next

The "bitcoin $100,000" price milestone has proven elusive. Some analysts are are blaming skittish investors taking profits as companies continue to purchase the crypto asset.

Bitcoin (BTCUSD), the largest cryptocurrency by market cap, rose to an all-time high 澳洲幸运5官方开奖结果体彩网:over $99,500 on Friday. The $100,000 mark seemed imminent. Now, however, it's closer to $9ꦅ2,000.

Bitcoin's rally picked up steam after 澳洲幸运5官方开奖结果体彩网:Donald Trump's electoral victory, with optimism regarding a more crypto-friendly administration and Congress that could pave the way for regulatory clarity the crypto-industry has been seeking helping to lift bitcoin and other crypto ass🌌ets.

Still, that rally has slowed lately. Some analysts say that is likely ꦑa result of profit-taking by relatively new investors i💛nto the asset, with longer-term investors holding on to their bitcoin.

Most of the selling "is coming from 2024 buyers who bought above 56k," said Galaxy Digital CEO Mike Novogratz in an X post Sunday, citing Galaxy's research. "Normal profit taking. Bitcoin analyst James Check said those who purchased bitcoin around $68,000 six weeks ago are responsible for a large amount of the selling pressure this month.

What's next? Read the 澳洲幸运5官方开奖结果体彩网:full story here.

-澳洲幸运5官方开奖结果体彩网:Kyle Torpey

Amgen Stock Sinks as Obesity Drug Test Results Disappoint

Amgen (AMGN) shares tanked Tuesday after💯 results from a test of the biotech's experimental weight-loss drug came in below expectaౠtions.

The company reported a 澳洲幸运5官方开奖结果体彩网:Phase 2 study of its injectable MariTide medicine 🉐s🎉howed an approximately 20% average weight loss over one year for patients who were obese or overweight without diabetes. In addition, Amgen noted the results were without a plateau, suggesting that even more pounds could be lost with additional use.

However, analysts were looking for better outcomes as compared with obesity treatments from Eli Lilly (LLY) and Novo Nordisk (NVO). They have also expressed worries about side effects and the number of patient🦂s that pulled out of the study. Citi wrote in a note that "concerns on pooled tolerability/discontinuation rates and overall competitiveness vis-à-vis Lilly or Novo has caused weakness in shares."

Jefferies analysts noted that expectations were for a 23% to 25% drop in weight. Still, they called the stock selloff was likely a "big overreaction" and an opportunity.

Amgen Chief Scientific Officer Dr. Jay Bradner explained that the results give the company confidence to initiate a Phase 3 study of MariTide. In addition, Amgen will be presenting the Phase 2 data "at a future medical congress and submitted for publication."

Amgen shares were down nearly 8% in ꦓrecent trading, leading decliners in the Dow Jones Industrial Average and trading at their lowest levels since April. The stock has lost 6% since the sta🌳rt of 2024.

-澳洲幸运5官方开奖结果体彩网:Bill McColl

Latest Trump Tariff News Hits Automaker Stocks

The latest trade news out of the next Trump administration has markets oꦏn the move, hitting big automakers’ shares and the stocks of America’s neighbors. 

Canadian and Mexican stocks were sliding Tuesday following the news that President-Elect Donald Trump said he would 澳洲幸运5官方开奖结果体彩网:impose stiff tariffs on imports from those countries. The iShares MCSI Mexico (EWW) and Canada (EWC)ꦉ exchange-traded funds were recen🅘tly off 3% and 1%, respectively. 

Among the stocks reacting to the news: some big global automakers. General Motors (GM), which makes many of its vehicles in Mexico, were recently off more than 8%, while Ford (F) shares fell 2%. Stellantis (STLA) fell more t�ཧ�han 5%. Volkswagen and Porsche were each down about 2% in German trading.

The Mexican peso and Canadian dollar weakened against the U🌳.S. dollar. 

Trump also said he plans an additional 10% tariff on goods from China. The Nasdaq Golden Dragon🔯 index of U.S-listed Chinese shares was recently off abo🧸ut 0.5%. 

-澳洲幸运5官方开奖结果体彩网:David Marino-Nachison

Best Buy Shares Sink as Results Hurt by Hesitant Consumers

Best Buy (BBY) shares tumbled Tuesday morning after the electronics retailer missed profit and sales estimates and slashed its guidance, as consumers pulled back on spending ahead of the key holiday shopping seasonও.

Best Buy posted fiscal 2025 third-quarter 澳洲幸运5官方开奖结果体彩网:earnings per share of $1.26, with revenue falling more than 3% year-over-year to $9.45 billio꧅n. Analysts surveyed by Visibl💯e Alpha were looking for $1.29 and $9.63 billion, respectively.

澳洲幸运5官方开奖结果体彩网:Comparable store sales fell 2.9%, dragged down by slowing purchases of appliances, home theate🍎r, a♔nd gaming items. International comparable store sales were down 3.7%, and online comparable store

CEO Corie Barry said "a combination of the ongoing macro uncertainty, customers waiting for deals and sales events, and distraction during the run-up to the election, particularly in non-essential categories, led to softer-than-expected demand" in the second half of the quarter.

The company predicts full-year EPS of $6.10 to $6.25, compared with the prior outlook of $6.10 to $6.35. It sees revenue of $41.1 billion to $41.5 billion, versus the earlier $41.3 billion to $41.9 billion. It expects comparable store sales will sink 2.5% to 3.5%, down from a 1.5% tꦕo 3.0% decline previously.  

Best Buy shares were down 7% in recent trading, narrowing their year-🌃to-date gains to 11%.

-澳洲幸运5官方开奖结果体彩网:Bill McColl

Kohl's Stock Tumbles After Weak Results, CEO Departure

Kohl's (KSS) shares plunged Tuesday morning after the retailer posted weakღer-than-expected quarterly results and lowered its outlook.

The downbeat results and outlook come a day after the department store company said that CEO Tom Kingsbury is stepping down following less than two years running the 澳洲幸运5官方开奖结果体彩网:struggling retailer. Kingsbury, who was named CEO in February 2023, will leave his post on Jan. 15 and be replaced by As🌠hley Buchanan, CEO of The Michaels Companies.

Kohl's reported third-quarter net revenue fell 9% year-over-year to $3.51 billion, with profit of $22 million, or 20 cents per share. Analysts polled by Visible Alpha expected $3.85 billion in revenue, with net income of $29.8 million, or 27 cents per share.

Kohl's lowered its outlook for full-year net sales, now forecasting them to decline by 7% to 8%, down from its prior projection of a 4% to 6% decrease. It also lowered its 2024 澳洲幸运5官方开奖结果体彩网:earnings per share (EPS) estimate to $1.20 to $1.50 from $1.75 to ♒$2.25.4

Kohl's shares were down 20% recently, trading at their lowest levels since April 2020, at the start of the COVID-19 pandemic.

-澳洲幸运5官方开奖结果体彩网:Nisha Gopalan

Tesla Stock Price Levels to Watch as Rally Stalls

Tesla (TSLA) shares were little changed early Tuesday after falling 4% yesterday amid uncertainty over new California electric vehicle (EV) 澳洲幸运5官方开奖结果体彩网:tax credits and bearis🏅h comment🎶ary from analysts at UBS.

On Monday, California Governor Gavin Newsom said that the state would provide EV tax credits if the Trump administration removed them at the federal level. However, Newsom added that the rebates would promote innovation and competition in the 澳洲幸运5官方开奖结果体彩网:zero emission vehicle (ZEV) market, suggesting that they would apply to 🌌smaller EV makers th⛎an Tesla.

Sentiment may have also taken a dent yesterday after UBS analyst Joseph Spak said in a research note that the stock’s recent post-election run up had been driven by “澳洲幸运5官方开奖结果体彩网:animal spirits,” rather than fundamental changes⭕ at the company.

Tesla shares have surged around 35% since election day, with investors betting that CEO 澳洲幸运5官方开奖结果体彩网:Elon Musk’s close relationship with the President elect will benefit the automaker, possibly through eased 澳洲幸运5官方开奖结果体彩网:self-driving regulations. The stock was up slightly at around $339 in recent pre💮market tradin🥂g Tuesday.

The stock's recent bullish price momentum may have temporarily hit the skids after the shares initially climbed to their highest level in more than two years on Monday before undergoing an intraday reversal to close near the day’s low.

Investors should watch key support levels on Tesla's chart around $310 and $265, while watching a bullish bars pattern price target near $500.

Read the full 澳洲幸运5官方开奖结果体彩网:technical analysis piece here.

-澳洲幸运5官方开奖结果体彩网:Timothy Smith

Stock Futures Point to Mixed Open for Major Indexes

Futures tied ꧂to the Dow Jones Industrial Average were do🧔wn less than 0.1%.

S&P 500 futures were up 0.3%.

Nasdaq 100 futures were also up 0.3%.